CINECA IRIS Institutional Research Information System

BARAULT, LUDOVIC
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.208
EU - Europa 1.164
AS - Asia 833
AF - Africa 47
SA - Sud America 22
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.289
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.138
CN - Cina 427
IT - Italia 426
GB - Regno Unito 133
KR - Corea 104
CZ - Repubblica Ceca 76
DE - Germania 71
RU - Federazione Russa 71
NL - Olanda 66
FR - Francia 63
CA - Canada 61
IN - India 55
JP - Giappone 42
ES - Italia 40
CH - Svizzera 33
FI - Finlandia 31
HK - Hong Kong 30
VN - Vietnam 30
SZ - Regno dello Swaziland 27
TR - Turchia 24
TW - Taiwan 24
UA - Ucraina 24
SE - Svezia 17
TH - Thailandia 17
BE - Belgio 16
SG - Singapore 15
ID - Indonesia 13
PL - Polonia 13
RO - Romania 12
ZA - Sudafrica 12
AU - Australia 11
GR - Grecia 11
LV - Lettonia 10
AT - Austria 9
BR - Brasile 9
HU - Ungheria 9
MX - Messico 9
PH - Filippine 9
IR - Iran 8
MY - Malesia 7
IL - Israele 6
AE - Emirati Arabi Uniti 5
DK - Danimarca 5
IE - Irlanda 5
MK - Macedonia 5
BY - Bielorussia 4
CO - Colombia 4
AR - Argentina 3
BD - Bangladesh 3
CL - Cile 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
UG - Uganda 3
JO - Giordania 2
PK - Pakistan 2
PT - Portogallo 2
SA - Arabia Saudita 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BJ - Benin 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BT - Bhutan 1
ET - Etiopia 1
EU - Europa 1
HR - Croazia 1
IS - Islanda 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
PE - Perù 1
RS - Serbia 1
SI - Slovenia 1
TN - Tunisia 1
VE - Venezuela 1
Totale 3.289
Salva come PNG Salva come JPEG
Città #
Fairfield 83
Torino 80
Ashburn 64
Beijing 61
Houston 61
Woodbridge 58
Seattle 55
Shanghai 51
Milan 48
Mountain View 46
Santa Cruz 46
Buffalo 41
Cambridge 36
Wilmington 33
Guangzhou 31
Seongnam 31
Wuhan 31
Ann Arbor 30
Nanjing 25
Lappeenranta 24
Dong Ket 21
Taipei 21
Turin 20
Mbabane 19
Rome 19
Xian 18
Tappahannock 17
Ottawa 15
Riva 15
Seoul 15
Tokyo 15
Burlington 14
Los Angeles 14
London 13
University Park 13
Chengdu 12
Chicago 12
Jakarta 12
Menlo Park 12
Nanning 12
New Orleans 12
Zurich 12
Barcelona 11
Hangzhou 11
Pisa 11
Bangkok 10
Central District 10
New York 10
Shenyang 10
Asheville 9
Boardman 9
Brussels 9
Chennai 9
Chongqing 9
Fuzhou 9
San Diego 9
Boston 8
Dearborn 8
Hamilton 8
Manzini 8
Zhengzhou 8
Changsha 7
Jinan 7
Lake Forest 7
Las Vegas 7
Norwalk 7
Philadelphia 7
San Mateo 7
Singapore 7
Tianjin 7
Bengaluru 6
Bergamo 6
Bologna 6
Changchun 6
Council Bluffs 6
Duncan 6
Leipzig 6
Paris 6
Toronto 6
Vienna 6
Warsaw 6
Absecon 5
Baltimore 5
Budapest 5
Central 5
Delhi 5
Helsinki 5
Hyderabad 5
Izmir 5
Muizenberg 5
Munich 5
New Haven 5
Phoenix 5
Settimo Torinese 5
Timisoara 5
Ankara 4
Athens 4
Brescia 4
Cardiff 4
Chiang Mai 4
Totale 1.663
Salva come PNG Salva come JPEG
Nome #
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth, file e27ce42c-7e04-2581-e053-d805fe0acbaa 749
BRAF V600E is a determinant of sensitivity to proteasome inhibitors., file e27ce426-ffd1-2581-e053-d805fe0acbaa 482
Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer, file e27ce42c-ac40-2581-e053-d805fe0acbaa 403
Colorectal cancer early methylation alterations affect the crosstalk between cell and surrounding environment, tracing a biomarker signature specific for this tumor, file e27ce42c-b05b-2581-e053-d805fe0acbaa 241
MGMT methylation assessed by methyl-BEAMing technique is a prognostic and predictive biomarker in glioblastoma and metastatic colorectal cancer patients, file e27ce427-0386-2581-e053-d805fe0acbaa 188
Molecular landscape of acquired resistance to targeted therapy combinations in BRAF mutant colorectal cancer, file e27ce428-ee7a-2581-e053-d805fe0acbaa 184
Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal cancer patients, file e27ce435-9a5d-2581-e053-d805fe0acbaa 171
A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology, file e27ce42e-7735-2581-e053-d805fe0acbaa 149
Evolving neoantigen profiles in colorectal cancers with DNA repair defects, file e27ce42e-a91a-2581-e053-d805fe0acbaa 128
Digital PCR assessment of MGMT promoter methylation coupled with reduced protein expression optimises prediction of response to alkylating agents in metastatic colorectal cancer patients, file e27ce42b-34b5-2581-e053-d805fe0acbaa 123
High Circulating Methylated DNA Is a Negative Predictive and Prognostic Marker in Metastatic Colorectal Cancer Patients Treated With Regorafenib., file e27ce42e-9c36-2581-e053-d805fe0acbaa 102
MET-driven resistance to dual EGFR and BRAF blockade may be overcome by switching from EGFR to MET inhibition in BRAF mutated colorectal cancer, file e27ce429-c87b-2581-e053-d805fe0acbaa 85
Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer, file e27ce427-3a7d-2581-e053-d805fe0acbaa 83
Circulating methylated DNA to monitor the dynamics of RAS mutation clearance in plasma from metastatic colorectal cancer patients, file e27ce431-364d-2581-e053-d805fe0acbaa 69
BRAF V600E is a determinant of sensitivity to proteasome inhibitors., file e27ce426-ffd2-2581-e053-d805fe0acbaa 63
Temozolomide and irinotecan (TEMIRI regimen) as salvage treatment of irinotecan-sensitive advanced colorectal cancer patients bearing MGMT methylation, file e27ce42d-dfce-2581-e053-d805fe0acbaa 62
Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal cancer patients, file e27ce435-9a5b-2581-e053-d805fe0acbaa 45
Tumor MGMT promoter hypermethylation changes over time limit temozolomide efficacy in a phase II trial for metastatic colorectal cancer, file e27ce428-f1c8-2581-e053-d805fe0acbaa 14
Refining the selection of patients with metastatic colorectal cancer for treatment with temozolomide using proteomic analysis of O6-methylguanine-DNA-methyltransferase, file e27ce42d-dabd-2581-e053-d805fe0acbaa 9
Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal cancer patients, file f2908de7-b6e6-471c-be4a-be1fde87a37a 9
Molecular landscape of acquired resistance to targeted therapy combinations in BRAF mutant colorectal cancer, file e27ce432-5e80-2581-e053-d805fe0acbaa 8
Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal cancer patients, file e27ce435-9a5c-2581-e053-d805fe0acbaa 8
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth, file e27ce42c-77f6-2581-e053-d805fe0acbaa 7
A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology, file e27ce42e-7a1f-2581-e053-d805fe0acbaa 6
True conversions from RAS mutant to RAS wild-type in circulating tumor DNA from metastatic colorectal cancer patients as assessed by methylation and mutational signature, file e27ce435-2ab3-2581-e053-d805fe0acbaa 4
Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer, file e27ce42c-4688-2581-e053-d805fe0acbaa 3
Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer, file e27ce427-39fa-2581-e053-d805fe0acbaa 2
Tumor MGMT promoter hypermethylation changes over time limit temozolomide efficacy in a phase II trial for metastatic colorectal cancer, file e27ce428-efe2-2581-e053-d805fe0acbaa 2
Digital PCR assessment of MGMT promoter methylation coupled with reduced protein expression optimises prediction of response to alkylating agents in metastatic colorectal cancer patients, file e27ce42a-f684-2581-e053-d805fe0acbaa 2
Preclinical efficacy of carfilzomib in BRAF-mutant colorectal cancer models, file 7408d2ea-9bcd-4763-a5c8-f33d578565e7 1
MET-driven resistance to dual EGFR and BRAF blockade may be overcome by switching from EGFR to MET inhibition in BRAF mutated colorectal cancer, file e27ce429-c87c-2581-e053-d805fe0acbaa 1
Molecular landscape of acquired resistance to targeted therapy combinations in BRAF mutant colorectal cancer, file e27ce429-cb90-2581-e053-d805fe0acbaa 1
Temozolomide and irinotecan (TEMIRI regimen) as salvage treatment of irinotecan-sensitive advanced colorectal cancer patients bearing MGMT methylation, file e27ce42d-dd61-2581-e053-d805fe0acbaa 1
Refining the selection of patients with metastatic colorectal cancer for treatment with temozolomide using proteomic analysis of O6-methylguanine-DNA-methyltransferase, file e27ce42d-eaff-2581-e053-d805fe0acbaa 1
Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer, file e27ce42f-7382-2581-e053-d805fe0acbaa 1
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth, file e27ce432-4e12-2581-e053-d805fe0acbaa 1
A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology, file e27ce432-5ec5-2581-e053-d805fe0acbaa 1
Totale 3.409
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.173
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.173
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019104 0 0 0 0 0 0 0 0 0 0 72 32
2019/2020668 53 29 39 64 47 42 60 74 77 69 53 61
2020/2021715 48 53 56 56 67 44 48 63 79 94 54 53
2021/2022768 74 58 68 57 80 34 65 32 60 43 73 124
2022/2023646 31 35 95 65 76 59 57 47 89 42 40 10
2023/2024102 5 3 7 4 10 6 11 15 7 31 3 0
Totale 3.409